Overview

For patients with advanced lung cancer, time matters. Capturing a Living Picture of CancerUnderstand more than just the tumor … understand the cancer disease state: the tumor mutation profile (GeneStrat) and patient response to the tumor (VeriStrat.)

VeriStrat and GeneStrat are blood tests that provide important information within 72 hours to help guide treatment decisions.

 

  • VeriStrat®
    is a predictive and prognostic test for patients with advanced non-small cell lung cancer (NSCLC)

    • VeriStrat Poor signature correlates with a more aggressive disease for all lines of therapy
    • VeriStrat Good signature correlates with a more favorable prognosis for all lines of therapy
    • VeriStrat classification is also predictive of differential treatment benefit for single agent therapy